Login to Your Account



Xenova Gets US$1.5M From Sale Of KSB's Monoclonal Business

By Nuala Moran


Wednesday, January 7, 2004
No Abstract

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription